• Home
  • News
  • Calendar
  • About DF/HCC
  • Membership
  • Visitor Center

April F. Eichler, MD


  • Batchelor TT, Gerstner ER, Emblem KE, Duda DG, Kalpathy-Cramer J, Snuderl M, Ancukiewicz M, Polaskova P, Pinho MC, Jennings D, Plotkin SR, Chi AS, Eichler AF, Dietrich J, Hochberg FH, Lu-Emerson C, Iafrate AJ, Ivy SP, Rosen BR, Loeffler JS, Wen PY, Sorensen AG, Jain RK.Improved tumor oxygenation and survival in glioblastoma patients who show increased blood perfusion after cediranib and chemoradiation.Proc Natl Acad Sci U S A. 2013 Nov 19;110(47):19059-64.
  • Lin NU, Freedman RA, Ramakrishna N, Younger J, Storniolo AM, Bellon JR, Come SE, Gelman RS, Harris GJ, Henderson MA, Macdonald SM, Mahadevan A, Eisenberg E, Ligibel JA, Mayer EL, Moy B, Eichler AF, Winer EP.A phase I study of lapatinib with whole brain radiotherapy in patients with Human Epidermal Growth Factor Receptor 2 (HER2)-positive breast cancer brain metastases.Breast Cancer Res Treat. 2013 Nov;142(2):405-14.
  • Lu-Emerson C, Snuderl M, Kirkpatrick ND, Goveia J, Davidson C, Huang Y, Riedemann L, Taylor J, Ivy P, Duda DG, Ancukiewicz M, Plotkin SR, Chi AS, Gerstner ER, Eichler AF, Dietrich J, Stemmer-Rachamimov AO, Batchelor TT, Jain RK.Increase in tumor-associated macrophages after antiangiogenic therapy is associated with poor survival among patients with recurrent glioblastoma.Neuro Oncology. 2013 Aug;15(8):1079-87.
  • Drappatz J, Brenner A, Wong ET, Eichler A, Schiff D, Groves MD, Mikkelsen T, Rosenfeld S, Sarantopoulos J, Meyers CA, Fielding RM, Elian K, Wang X, Lawrence B, Shing M, Kelsey S, Castaigne JP, Wen PY.Phase I study of GRN1005 in recurrent malignant glioma.Clin Cancer Res. 2013 Mar 15;19(6):1567-76.
  • Volandes AE, Paasche-Orlow MK, Mitchell SL, El-Jawahri A, Davis AD, Barry MJ, Hartshorn KL, Jackson VA, Gillick MR, Walker-Corkery ES, Chang Y, López L, Kemeny M, Bulone L, Mann E, Misra S, Peachey M, Abbo ED, Eichler AF, Epstein AS, Noy A, Levin TT, Temel JS.Randomized controlled trial of a video decision support tool for cardiopulmonary resuscitation decision making in advanced cancer.J Clin Oncol. 2013 Jan 20;31(3):380-6.
  • Kodack DP, Chung E, Yamashita H, Incio J, Duyverman AM, Song Y, Farrar CT, Huang Y, Ager E, Kamoun W, Goel S, Snuderl M, Lussiez A, Hiddingh L, Mahmood S, Tannous BA, Eichler AF, Fukumura D, Engelman JA, Jain RK.Combined targeting of HER2 and VEGFR2 for effective treatment of HER2-amplified breast cancer brain metastases.Proc Natl Acad Sci U S A. 2012 Nov 6;109(45):E3119-27.
  • Panageas KS, Iwamoto FM, Cloughesy TF, Aldape KD, Rivera AL, Eichler AF, Louis DN, Paleologos NA, Fisher BJ, Ashby LS, Cairncross JG, Roldán Urgoiti GB, Wen PY, Ligon KL, Schiff D, Robins HI, Rocque BG, Chamberlain MC, Mason WP, Weaver SA, Green RM, Kamar FG, Abrey LE, Deangelis LM, Jhanwar SC, Rosenblum MK, Lassman AB.Initial treatment patterns over time for anaplastic oligodendroglial tumors.Neuro Oncology. 2012 Jun;14(6):761-7.
  • Eichler AF, Kahle KT, Wang DL, Joshi VA, Willers H, Engelman JA, Lynch TJ, Sequist LV.EGFR mutation status and survival after diagnosis of brain metastasis in nonsmall cell lung cancer.Neuro Oncology. 2010 Nov;12(11):1193-9.
  • Gerstner ER, Eichler AF, Plotkin SR, Drappatz J, Doyle CL, Xu L, Duda DG, Wen PY, Jain RK, Batchelor TT.Phase I trial with biomarker studies of vatalanib (PTK787) in patients with newly diagnosed glioblastoma treated with enzyme inducing anti-epileptic drugs and standard radiation and temozolomide.J. Neurooncol. 2010 Sep 7.
  • Batchelor TT, Duda DG, di Tomaso E, Ancukiewicz M, Plotkin SR, Gerstner E, Eichler AF, Drappatz J, Hochberg FH, Benner T, Louis DN, Cohen KS, Chea H, Exarhopoulos A, Loeffler JS, Moses MA, Ivy P, Sorensen AG, Wen PY, Jain RK.Phase II study of cediranib, an oral pan-vascular endothelial growth factor receptor tyrosine kinase inhibitor, in patients with recurrent glioblastoma.J Clin Oncol. 2010 Jun 10;28(17):2817-23.
  • El-Jawahri A, Podgurski LM, Eichler AF, Plotkin SR, Temel JS, Mitchell SL, Chang Y, Barry MJ, Volandes AE.Use of video to facilitate end-of-life discussions with patients with cancer: a randomized controlled trial.J Clin Oncol. 2010 Jan 10;28(2):305-10.
  • Costello DJ, Eichler AF, Eichler FS.Leukodystrophies: classification, diagnosis, and treatment.Neurologist. 2009 Nov;15(6):319-28. Review.
  • Eichler AF, Lamont EB.Utility of administrative claims data for the study of brain metastases: a validation study.J. Neurooncol. 2009 Dec;95(3):427-31.
  • Snuderl M, Eichler AF, Ligon KL, Vu QU, Silver M, Betensky RA, Ligon AH, Wen PY, Louis DN, Iafrate AJ.Polysomy for chromosomes 1 and 19 predicts earlier recurrence in anaplastic oligodendrogliomas with concurrent 1p/19q loss.Clin Cancer Res. 2009 Oct 15;15(20):6430-7.
  • Eichler AF,Plotkin SR.Brain metastases.Curr Treat Options Neurol. 2008 Jul;10(4):308-14.
  • Eichler AF, Kuter I, Ryan P, Schapira L, Younger J, Henson JW.Survival in patients with brain metastases from breast cancer: the importance of HER-2 status.Cancer. 2008 Jun;112(11):2359-67.
  • Eichler AF, Loeffler JS.Multidisciplinary management of brain metastases.Oncologist. 2007 Jul;12(7):884-98. Review.
  • Eichler AF, Batchelor TT, Henson JW.Diffusion and perfusion imaging in subacute neurotoxicity following high-dose intravenous methotrexate.Neuro-oncol. 2007 Jul;9(3):373-7.
  • Eichler AF, Batchelor TT.Primary central nervous system lymphoma: presentation, diagnosis and staging.Neurosurg Focus. 2006;21(5):E15. Review.
  • Fitzsimmons A, Upchurch K, Batchelor T.Clinical features and diagnosis of primary central nervous system lymphoma.Hematol Oncol Clin North Am. 2005 Aug;19(4):689-703, vii.
  • Smith EE, Fitzsimmons AL, Nogueira RG, Singhal AB.Spontaneous hyperacute postischemic hemorrhage leading to death.J Neuroimaging. 2004 Oct;14(4):361-4.
  • Webber SA, Bentlejeweski C, Boyle GJ, Law Y, Bowman P, Miller SA, Gribar S, Fitzsimmons A, McCurry K, Murali S, Griffith B, Zeevi A.Indirect alloresponses are more pronounced in non-rejecting lung than heart allografts.J Heart Lung Transplant. 2001 Feb;20(2):165-166.